NL-OMON25709
Recruiting
N/A
Maternal and fetal/neonatal pharmacokinetics and - dynamics of corticosteroids during pregnancy as treatment for fetal lung maturation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus MC
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •1\)Older than 18 years of age.
- •2\)Admitted at the Department of Obstetrics at Erasmus MC – Sophia for suspicion of preterm birth with a gestational age of 23\+5 weeks until 33\+6 weeks.
- •3\)Understanding of Dutch in speaking and reading.
- •4\)Written informed consent.
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •1\)Women unable or unwilling to agree with the procedures.
- •2\)Women unable or unwilling to give written informed consent.
- •3\)Women with acute obstetric complications requiring immediate delivery at time of admission.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Maternal and fetal/neonatal pharmacokinetics and - dynamics of corticosteroids during pregnancy as treatment for fetal lung maturatiopremature contractionsPreterm birth10010273NL-OMON56400Erasmus MC, Universitair Medisch Centrum Rotterdam400
Not Yet Recruiting
Phase 2
Maternal pharmacokinetics and pharmacodynamics of nicardipine (iv) during treatment of severe hypertension in pregnancy.preeclampsia1002690810057166NL-OMON36863Erasmus MC, Universitair Medisch Centrum Rotterdam40
Active, Not Recruiting
N/A
What is the effect of nicardipine on the pregnant woman with severe hypertension and how is nicardipine excreted?EUCTR2012-005330-10-NLErasmus University Medical Centre
Recruiting
N/A
Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During PregnancyPreterm BirthNCT06264973Erasmus Medical Center100
Recruiting
Phase 3
nderstanding metabolism of drug and changes in human functioning for drug given to pregnant women at risk of late preterm birthHealth Condition 1: P220- Respiratory distress syndrome of newbornCTRI/2023/10/058248World Health Organization